| Small-molecule PAPD5 inhibitors restore telomerase activity in patient stem cells N Nagpal, J Wang, J Zeng, E Lo, DH Moon, K Luk, RO Braun, ... Cell stem cell 26 (6), 896-909. e8, 2020 | 73 | 2020 |
| Assessment of engineered cells using CellNet and RNA-seq AH Radley, RM Schwab, Y Tan, J Kim, EKW Lo, P Cahan Nature protocols 12 (5), 1089-1102, 2017 | 53 | 2017 |
| Effective range of non-cell autonomous activator and inhibitor peptides specifying plant stomatal patterning SM Zeng, EKW Lo, BJ Hazelton, MF Morales, KU Torii Development 147 (17), dev192237, 2020 | 14 | 2020 |
| Comprehensive DNA methylation analysis indicates that pancreatic intraepithelial neoplasia lesions are acinar-derived and epigenetically primed for carcinogenesis EKW Lo, BM Mears, HC Maurer, A Idrizi, KD Hansen, ED Thompson, ... Cancer Research 83 (11), 1905-1916, 2023 | 6 | 2023 |
| Engineering Skeletal Muscle Grafts with PAX7:: GFP-Sorted Human Pluripotent Stem Cell-Derived Myogenic Progenitors on Fibrin Microfiber Bundles for Tissue Regeneration SM Somers, J Gilbert-Honick, IY Choi, E KW Lo, HT Lim, S Dias, ... Bioengineering 9 (11), 693, 2022 | 3 | 2022 |
| Platform-agnostic CellNet enables cross-study analysis of cell fate engineering protocols EKW Lo, JJ Velazquez, D Peng, C Kwon, MR Ebrahimkhani, P Cahan Stem Cell Reports 18 (8), 1721-1742, 2023 | 2 | 2023 |
| Cell Fate Engineering Tools for iPSC Disease Modeling EKW Lo, P Cahan Computational Stem Cell Biology: Methods and Protocols, 427-454, 2019 | 2 | 2019 |
| Single cell and spatial transcriptomics analysis of kidney double negative T lymphocytes in normal and ischemic mouse kidneys S Gharaie, K Lee, K Noller, EK Lo, B Miller, HJ Jung, AM Newman-Rivera, ... Scientific Reports 13 (1), 20888, 2023 | 1 | 2023 |
| The people behind the papers-Emily Lo and Keiko Torii E Lo, K Torii DEVELOPMENT 147 (17), 2020 | | 2020 |
| Evaluation of Bunina et al.: Synthesizing Multi-omics Data to Delineate Neuronal Differentiation EKW Lo, EY Su, P Cahan Cell Systems 10 (6), 459-460, 2020 | | 2020 |
